We are live on
!
Find out more
WSCM
Wellington Shields Capital Management Portfolio holdings
AUM
$666M
1-Year Est. Return
45.43%
This Fund
S&P 500
This Quarter
Est. Return
+2.55%
1 Year Est. Return
+45.43%
3 Year Est. Return
+80.5%
5 Year Est. Return
+105.84%
10 Year Est. Return
+356.21%
AUM
$831M
AUM Growth
+$7.15M
(+0.87%)
Cap. Flow
+$19.4M
Cap. Flow
% of AUM
2.34%
Top 10 Holdings %
Top 10 Hldgs %
63.48%
Holding
334
New
21
Increased
86
Reduced
62
Closed
14
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Mastercard
MA
|
+$6.06M |
| 2 |
Apple
AAPL
|
+$4.92M |
| 3 |
Salesforce
CRM
|
+$4.34M |
| 4 |
Primerica
PRI
|
+$3.86M |
| 5 |
Thermo Fisher Scientific
TMO
|
+$3.51M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$7.39M |
| 2 |
Chevron
CVX
|
+$3.25M |
| 3 |
iShares Biotechnology ETF
IBB
|
+$2.34M |
| 4 |
Royalty Pharma
RPRX
|
+$1.9M |
| 5 |
Carlyle Group
CG
|
+$1.57M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Staples | 49.79% |
| 2 | Technology | 11.4% |
| 3 | Healthcare | 8.32% |
| 4 | Financials | 8.07% |
| 5 | Industrials | 5.58% |
Similar funds
BCP
CWP
TAP
IACCIA
MIA
AGM
SHFA
AO
Wellington Shields Capital Management's Q1 2023 Portfolio in Review
As of Q1 2023, Wellington Shields Capital Management held 334 positions worth $831M, up 0.87% from $824M the previous quarter. Its ten largest holdings account for 63% of the portfolio.
Wellington Shields Capital Management's Q1 2023 filing shows 21 new, 86 increased, 62 reduced and 14 closed positions. Its largest new stake was Ares Capital: 130,655 shares worth $2.39M. The largest sale was Johnson & Johnson, an estimated $7.39M.
By sector, the portfolio is most concentrated in Consumer Staples at 50% of assets, down from 52% a quarter earlier, followed by Technology and Healthcare.
- Wellington Shields Capital Management's largest Q1 2023 buy was Ares Capital: 130,655 shares worth $2.39M.
- Wellington Shields Capital Management added most to Mastercard in Q1 2023, an estimated $6.06M increase.
- Wellington Shields Capital Management's biggest Q1 2023 reduction was Johnson & Johnson, cutting an estimated $7.39M.
- Wellington Shields Capital Management fully exited iShares Biotechnology ETF in Q1 2023, selling an estimated $2.34M.
- Wellington Shields Capital Management's ten largest holdings make up 63% of its $831M portfolio in Q1 2023.
- Wellington Shields Capital Management opened 21 new positions and closed 14 in Q1 2023.
- Wellington Shields Capital Management's portfolio value rose 0.87% quarter-over-quarter to $831M.
Based on Wellington Shields Capital Management's 13F filing for Q1 2023, filed 11 May 2023.